| Dr Brandon Bultsma, DPM | |
|
1565 Sam Rittenberg Blvd Ste 104, Charleston, SC 29407-4128 | |
| (854) 444-3129 | |
| Not Available |
| Full Name | Dr Brandon Bultsma |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 10 Years |
| Location | 1565 Sam Rittenberg Blvd Ste 104, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033522784 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 707 (South Carolina) | Primary |
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 5901002526 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours-st Francis Xavier Hospital | Charleston, SC | Hospital |
| Roper Hospital | Charleston, SC | Hospital |
| Provider Name | Lanny S. Foster, D.p.m., P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1639340177 PECOS PAC ID: 3274611652 Enrollment ID: O20080425000177 |
News Archive
One of the most common initial red flags reported by parents of children with autism is that they suspect their child may be deaf because he or she no longer responds to his or her name, and does not look at them when they speak. However, the lack of response or eye contact can point to an Autism Spectrum Disorder. In fact, many children on the autism spectrum do not demonstrate typical language skills and social behavior, or even lose language or social skills they once had.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease. One finding offers a critical message regarding treatment strategy, they say.
New research discovers a combination of drugs that may prove to be a more effective treatment for a lethal form of leukemia. The study, published by Cell Press in the May issue of the journal Cancer Cell, reports that the new therapeutic strategy effectively targets notoriously intractable leukemia stem cells that often escape standard treatment and are a main factor in disease relapse.
› Verified 9 days ago
| Provider Name | Richmond Foot And Ankle Clinic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1255688818 PECOS PAC ID: 6002065760 Enrollment ID: O20121110000039 |
News Archive
One of the most common initial red flags reported by parents of children with autism is that they suspect their child may be deaf because he or she no longer responds to his or her name, and does not look at them when they speak. However, the lack of response or eye contact can point to an Autism Spectrum Disorder. In fact, many children on the autism spectrum do not demonstrate typical language skills and social behavior, or even lose language or social skills they once had.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease. One finding offers a critical message regarding treatment strategy, they say.
New research discovers a combination of drugs that may prove to be a more effective treatment for a lethal form of leukemia. The study, published by Cell Press in the May issue of the journal Cancer Cell, reports that the new therapeutic strategy effectively targets notoriously intractable leukemia stem cells that often escape standard treatment and are a main factor in disease relapse.
› Verified 9 days ago
| Provider Name | Brandon C Bultsma Dpm Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1396232880 PECOS PAC ID: 0840548475 Enrollment ID: O20180730002150 |
News Archive
One of the most common initial red flags reported by parents of children with autism is that they suspect their child may be deaf because he or she no longer responds to his or her name, and does not look at them when they speak. However, the lack of response or eye contact can point to an Autism Spectrum Disorder. In fact, many children on the autism spectrum do not demonstrate typical language skills and social behavior, or even lose language or social skills they once had.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease. One finding offers a critical message regarding treatment strategy, they say.
New research discovers a combination of drugs that may prove to be a more effective treatment for a lethal form of leukemia. The study, published by Cell Press in the May issue of the journal Cancer Cell, reports that the new therapeutic strategy effectively targets notoriously intractable leukemia stem cells that often escape standard treatment and are a main factor in disease relapse.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brandon Bultsma, DPM 3558 Rookwood Pl, Johns Island, SC 29455-8183 Ph: (854) 444-3129 | Dr Brandon Bultsma, DPM 1565 Sam Rittenberg Blvd Ste 104, Charleston, SC 29407-4128 Ph: (854) 444-3129 |
News Archive
One of the most common initial red flags reported by parents of children with autism is that they suspect their child may be deaf because he or she no longer responds to his or her name, and does not look at them when they speak. However, the lack of response or eye contact can point to an Autism Spectrum Disorder. In fact, many children on the autism spectrum do not demonstrate typical language skills and social behavior, or even lose language or social skills they once had.
Malignant gliomas are the most common subtype of primary brain tumor - and one of the deadliest. Even as doctors make steady progress treating other types of solid tumor cancers, from breast to prostate, the most aggressive form of malignant glioma, called a glioblastoma multiforme or GBM, has steadfastly defied advances in neurosurgery, radiation therapy and various conventional or novel drugs. But an international team of scientists, headed by researchers at the Ludwig Institute for Cancer Research (LICR) at the University of California, San Diego School of Medicine, reports in the August 15 issue of Genes & Development that they have discovered a new signaling pathway between GBM cells - one that, if ultimately blocked or disrupted, could significantly slow or reduce tumor growth and malignancy.
Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease. One finding offers a critical message regarding treatment strategy, they say.
New research discovers a combination of drugs that may prove to be a more effective treatment for a lethal form of leukemia. The study, published by Cell Press in the May issue of the journal Cancer Cell, reports that the new therapeutic strategy effectively targets notoriously intractable leukemia stem cells that often escape standard treatment and are a main factor in disease relapse.
› Verified 9 days ago
Marshall N. Kalinsky Dpm Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 325 Folly Rd, Ste 101, Charleston, SC 29412 Phone: 843-766-1632 Fax: 843-763-9430 | |
Dr. Brian G Ralph, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2270 Ashley Crossing Dr Ste 110, Charleston, SC 29414 Phone: 843-853-3474 Fax: 843-853-3500 | |
Dennis Emerson Martin, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9279 Medical Plaza Dr, Suite D, Charleston, SC 29406 Phone: 843-553-2223 Fax: 843-553-2275 | |
Dr. Matthew Fernandez, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1012 Physicians Dr, Charleston, SC 29414 Phone: 843-571-0602 | |
Musc Physicians Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Advanced Care Foot And Ankle Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 930 Folly Rd Ste D, Charleston, SC 29412 Phone: 843-606-0019 Fax: 843-604-0566 |